SAMSUNG PHARM. Co., LTD. (KRX: 001360)

SAMSUNG PHARM. Co., LTD. Revenue

SAMSUNG PHARM. Co., LTD. had revenue of 23.34B KRW in the quarter ending September 30, 2019, with 122.70% growth. This brings the company's revenue in the last twelve months to 44.65B, up 4.72% year-over-year. In the year 2018, SAMSUNG PHARM. Co., LTD. had annual revenue of 46.48B with 10.89% growth.

• Revenue (ttm): 44.65B
• Revenue Growth: +4.72%
• P/S Ratio: 2.42
• Revenue / Employee: 186.06M
• Employees: 240
• Market Cap: 174.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2018	46.48B	4.56B	10.89%
Dec 31, 2017	41.92B	-5.27B	-11.18%
Dec 31, 2016	47.19B	5.03B	11.93%
Dec 31, 2015	42.16B	11.88B	39.21%
Dec 31, 2014	30.29B	-17.00B	-35.95%